| Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210) |
|---|
| 08/18/2004 | EP1447445A1 PROBE SOLUTIN COMPOSITIONS, REACTIVE CHIP USING THE SAME AND PROCESS FOR THE PRODUCTION THEREOF |
| 08/18/2004 | EP1447444A1 Method of identifying prokaryotic gene structure |
| 08/18/2004 | EP1447442A1 Inosine production by means of Bacillus bacteria able to grow in the presence of 6-ethoxypurine |
| 08/18/2004 | EP1447413A2 Full-length human cDNA |
| 08/18/2004 | EP1447411A1 Novel protein, its dna and use thereof |
| 08/18/2004 | EP1447410A1 Control of plant growth and developmental processes |
| 08/18/2004 | EP1446733A2 Glycosylphosphatidylinositol containing polypeptides |
| 08/18/2004 | EP1446666A1 Method for detecting analyte(s) using magnetic colloidal particles |
| 08/18/2004 | EP1446508A2 A method of reducing non-specific amplification in pcr |
| 08/18/2004 | EP1446507A2 Therapeutics and diagnostics for disorders of erythropoiesis |
| 08/18/2004 | EP1446506A2 COMPOSITIONS, METHODS AND KITS FOR DETERMINING THE PRESENCE OF i MYCOPLASMA PNEUMONIAE /i AND/OR i MYCOPLASMA GENITALIUM /i IN A TEST SAMPLE |
| 08/18/2004 | EP1446504A2 Emulsion compositions |
| 08/18/2004 | EP1446503A2 Composition and methods for enhancing oligonucleotide-directed nucleic acid sequence alteration |
| 08/18/2004 | EP1446501A2 Methods for identification of cancer cell surface molecules and cancer specific promoters, and therapeutic uses thereof |
| 08/18/2004 | EP1446500A2 A method for regulating immune function in primates using the foxp3 protein |
| 08/18/2004 | EP1446495A2 Whole cell engineering using real-time metabolic flux analysis |
| 08/18/2004 | EP1446492A2 Process for the preparation of an enantiomerically enriched a-amino acid |
| 08/18/2004 | EP1446491A1 Method for production of asymmetric carotenoids |
| 08/18/2004 | EP1446490A1 Chimeric plasmid comprising a replicative retroviral genome and uses thereof |
| 08/18/2004 | EP1446489A2 Intact minicells as vectors for dna transfer and gene therapy in vitro and in vivo |
| 08/18/2004 | EP1446488A2 Regulated nucleic acid expression system |
| 08/18/2004 | EP1446487A1 Mammalian protein phosphatases |
| 08/18/2004 | EP1446486A1 Transgenic organism expressing fungal mrp-like abc transporters |
| 08/18/2004 | EP1446484A1 Nucleotide sequence coding for a modified protein of interest, expression vector and method for obtaining same |
| 08/18/2004 | EP1446483A2 Dna polymerase eta (pol.eta) cdna and uses thereof |
| 08/18/2004 | EP1446482A2 Compositions and methods for making mutations in cell lines and animals |
| 08/18/2004 | EP1446479A1 Recombinant adenovirus with enhanced therapeutic effect and pharmaceutical composition comprising said recombinant adenovirus |
| 08/18/2004 | EP1446478A2 Dimerized growth factor and materials and methods for producing it |
| 08/18/2004 | EP1446475A2 RECOMBINANT DNA PROCESSES USING A dNTP MIXTURE CONTAINING MODIFIED NUCLEOTIDES |
| 08/18/2004 | EP1446426A2 Peptide purification by means of metal ion affinity chromatography |
| 08/18/2004 | EP1446425A2 Treatment of micro-organism infection |
| 08/18/2004 | EP1446422A2 Methylated heparin-binding hemagglutinin recombinant mycobacterial antigen, preparation method and immunogenic compositions comprising same |
| 08/18/2004 | EP1446421A2 Mutated gene from corynebacterium glutamicum |
| 08/18/2004 | EP1446420A2 Virulence proteins of the genus yersinia and uses thereof |
| 08/18/2004 | EP1446419A2 Therapeutic polypeptides, nucleic acids encoding the same, and methods of use |
| 08/18/2004 | EP1446417A2 Novel epidermal growth factor protein and gene, and methods of use therefor |
| 08/18/2004 | EP1446416A1 Tumor specific monoclonal antibodies |
| 08/18/2004 | EP1446415A2 Detection and identification of enteric bacteria |
| 08/18/2004 | EP1446414A1 Differentially expressed genes associated with obesity and type 2 diabetes |
| 08/18/2004 | EP1446412A2 Novel lna compositions and uses thereof |
| 08/18/2004 | EP1446162A2 Combination motif immune stimulatory oligonucleotides with improved activity |
| 08/18/2004 | EP1446149A1 Pharmaceutical composition comprising factor vii polypeptides and factor v polypeptides |
| 08/18/2004 | EP1446139A2 Pharmaceutical composition containing sfcyr iib or sfcyr iii |
| 08/18/2004 | EP1446130A2 Ehrlichia canis genes and vaccines |
| 08/18/2004 | EP1446129A2 Polynucleotide therapy |
| 08/18/2004 | EP1446044A2 Pin1 as a marker for prostate cancer |
| 08/18/2004 | EP1446008A2 Compositions and methods for controlled release |
| 08/18/2004 | EP1446007A1 Methods and compositions for targeting underglycosylated proteins across the blood brain barrier |
| 08/18/2004 | EP1446004A1 Exogenous protein expression system in an avian system |
| 08/18/2004 | EP1379690A4 Oligonucleotide chip composition for analyzing hepatitis c virus (hcv) genotype and detecting method thereof |
| 08/18/2004 | EP1347678A4 Method to maintain a genic male-sterile female parental lines for the production of hybrid wheat |
| 08/18/2004 | EP1307563B1 Nucleotide sequences which code for the lysr2 gene |
| 08/18/2004 | EP1299557A4 Signal amplification with lollipop probes |
| 08/18/2004 | EP1261724A4 Topoisomerase linker-mediated amplification methods |
| 08/18/2004 | EP1194562B1 The lactose operon of lactobacillus delbrueckii and its use for controlling gene transcription and/or expression in bacterial cells |
| 08/18/2004 | EP1185680A4 Reverse transcription activity from bacillus stearothermophilus dna polymerase in the presence of magnesium |
| 08/18/2004 | EP1185669B1 Promoter enabling transgene expression in the whole plant except in the seed |
| 08/18/2004 | EP1183346A4 Method for generating split, non-transferable genes that are able to express an active protein product |
| 08/18/2004 | EP1129344B1 Methods and formulations for the separation of biological macromolecules |
| 08/18/2004 | EP1100876A4 Agrobacterium-mediated transformation of turfgrass |
| 08/18/2004 | EP1083882A4 A hepatocyte targeting polyethylene glyco-grafted poly-l-lysine polymeric gene carrier |
| 08/18/2004 | EP1073671A4 Targeted gene delivery to cells by filamentous bacteriophage |
| 08/18/2004 | EP1071747B1 Immortalised cell lines derived from normal human skin tissues |
| 08/18/2004 | EP1042502B1 Means for qualitative and quantitative analysis of microbial populations potentially present in a sample |
| 08/18/2004 | EP1040202A4 Dna polymorphism identity determination using flow cytometry |
| 08/18/2004 | EP1038025A4 Genetic alterations associated with cancer |
| 08/18/2004 | EP1012257A4 Methods and materials for making and using transgenic dicamba-degrading organisms |
| 08/18/2004 | EP1005533A4 Methods for screening nuclear transcription factors for the ability to modulate an estrogen response |
| 08/18/2004 | EP0977856B1 Lag-3 splice variants |
| 08/18/2004 | EP0954330A4 Intestinal trefoil proteins |
| 08/18/2004 | EP0951533A4 Vectors and methods for the mutagenesis of mammalian genes |
| 08/18/2004 | EP0946744B1 Novel polymeric complexes for the transfection of nucleic acids, with residues causing the destabilisation of cell membranes |
| 08/18/2004 | EP0881914B1 Methoxyethoxy oligonucleotides for modulation of protein kinase c expression |
| 08/18/2004 | EP0871730B1 Combination pdgf, kgf, igf and igfbp for wound healing |
| 08/18/2004 | EP0871474A4 Generation of human insulin |
| 08/18/2004 | EP0835137B1 Encapsulated cells producing viral particles |
| 08/18/2004 | EP0833920B1 Transferrin receptor genes |
| 08/18/2004 | EP0827544B1 Multimeric proteins |
| 08/18/2004 | EP0820507B1 Ndf peptides |
| 08/18/2004 | EP0817851B9 Dna encoding human papilloma virus type 18 |
| 08/18/2004 | EP0805870A4 Spectroscopically detectable nucleic acid ligands |
| 08/18/2004 | EP0804587B1 Mutant luciferases |
| 08/18/2004 | EP0706387B1 New procedure to block the replication of reverse transcriptase dependent viruses by the use of inhibitors of deoxynucleotides synthesis |
| 08/18/2004 | EP0663014B1 Dna encoding human alpha 1 adrenergic receptors and uses thereof |
| 08/18/2004 | EP0471011B2 HUMAN LACTOFERRIN cDNA SEQUENCE |
| 08/18/2004 | CN1522305A Amplification process |
| 08/18/2004 | CN1522304A Use of a biochip for the diagnosis of sepsis or sepsis related syndrome |
| 08/18/2004 | CN1522303A Method for detecting a risk of hypertension and uses thereof |
| 08/18/2004 | CN1522300A Novel maxizyme |
| 08/18/2004 | CN1522299A Coagulation factor vii derivatives |
| 08/18/2004 | CN1522264A 抗cd40单克隆抗体 Monoclonal antibody anti-cd40 |
| 08/18/2004 | CN1522160A Vector encoding human globin gene and use thereof in treatment of hemoglobinopathies |
| 08/18/2004 | CN1522156A Novel engineered superantigen for human therapy |
| 08/18/2004 | CN1521275A Multiple arrays with surface energy transition to maintain separation of samples on the arrays |
| 08/18/2004 | CN1521274A System and method for detecting biological and chemical material |
| 08/18/2004 | CN1521264A Process for preparing serine-rich protein employing cysteine synthase (cysk) gene |
| 08/18/2004 | CN1521263A PCR method |
| 08/18/2004 | CN1521261A Method for producing a peptide with a pi above 8 or below 5 |
| 08/18/2004 | CN1521260A Drosophila disease model for screening drug of restoring cranial nerve cell degeneration and constructing method and application thereof |
| 08/18/2004 | CN1521259A Drosophila disease model for screening anti-dementia drug and constructing method and application thereof |